AMANDA WINFORD: Open Payments
NPI 1316433998 · HARRISON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 26 payments from 14 companies in 2025. Trend: 2023 $293 · 2024 $267 · 2025 $518
Food & beverage: $492Education: $26
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $106 |
| ABBVIE INC. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Exact Sciences Corporation | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $20 |
Products named: Kerendia, VRAYLAR, CAPLYTA, Cologuard Collection Kit, Auvelity, REXULTI, QULIPTA, TRINTELLIX.
Industry payments across AR — which companies pay providers there.
